Online meeting held on issues regarding Sputnik-V vaccine

2021-03-05 15:30:27

Ulaanbaatar /MONTSAME/ Yesterday, March 4, an online meeting was held on issues regarding production, use, approval and registration of Sputnik-V vaccine developed by the Russian Federation.

Mongolia has become the 23rd country to approve the use of Sputnik-V vaccine for emergency use and received the first 10,000 doses of Sputnik-V vaccine on February 27.

The meeting was organized by Rossotrudnichestvo Representative Office in Mongolia with participation of representatives from media organizations, doctors and medical scientists of the two countries, Mongolian Red Cross Society and Red Crescent Society, Mongol Em Impex Concern and Intermed Hospital.

Opening the meeting, Head of Rossotrudnichestvo Representative Office in Mongolia A.R.Bazarhandayev provided information on Sputnik-V vaccine. Russia registered ‘world's first’ vaccine against COVID-19 on August 11, 2020. So far 38 countries including Mongolia, Kazakhstan, Argentina, Algeria, Belarus, Bolivia, Palestine, Venezuela, Paraguay, Kyrgyz, Uzbekistan, Hungary, Iran, the United Arab Emirates, Tunisia, Armenia, Bosnia-Herzegovina, Montenegro, Myanmar, Bahrein, Lithuania, Guatemala, San-Marino, Egypt, Siri, Honduras and Vietnam, authorized the Sputnik V vaccine for emergency use. Out of them, nine countries have received the vaccine while 5 countries started using the vaccine in their immunization.

Sputnik-V vaccine is being manufactured in several factories including Gamaleya Institute, Binnopharm, FarmSyntez, R-Farm, Biocad and Generium. As of today, Russia has officially approved three COVID-19 vaccines including Sputnik-V and “EpiVacCorona” developed by Vektor State Research Center of Virology and Biotechnology in Novosibirsk and “KoviVac” by Scientific Center named after M.P.Chumakov and using the vaccines domestically and in other countries.  

Dr. Kurban Aitov from Irkutsk State Medical University emphasized COVID vaccines developed by Russia have not shown any serious adverse effects.

Citing that the Mongolian Government is involving its population in immunization free of charge, Member of Parliament J.Chinburen noted that the country is facing the necessity to expand its vaccination. He also said “ Mongolia has become ready to use the Sputnik-V vaccine in immunization after its approval by the World Health Organization. I am confident that the Russian Federation would lead in development and production of other types of vaccines.”

Director in charge of Foreign Relations and Cooperation of ‘Mongol Em Impex Concern” LLC B.Munkh-Erdene said that our company is supplying other necessary medications that are required in time of COVID-19 pandemic aside from the coronavirus vaccine. We have made a number of researches and obtained information on vaccines being developed by world developed countries. In doing so, we found out Russia’s Sputnik-V vaccine has a high efficacy. Mongolia will receive 20 thousand doses of Sputnik-V vaccine by the order of Government. The first batch of 10 thousand doses of the vaccine was supplied to Mongolia on February 27 and the next batch of vaccine is expected to arrive by March 10. A negotiation to bring 200-250 thousand doses of vaccine monthly further is under discussion.